The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis
Open accessAbstract
The chemokine CXCL12 (SDF-1) and its cell surface receptor CXCR4 were first identified as regulators of lymphocyte trafficking to the bone marrow. Soon after, the CXCL12/CXCR4 axis was proposed to regulate the trafficking of breast cancer cells to sites of metastasis. More recently, it was established that CXCR4 plays a central role in cancer cell proliferation, invasion, and dissemination in the majority of malignant diseases. The stem cell concept of cancer has revolutionized the understanding of tumorigenesis and cancer treatment. A growing body of evidence indicates that a subset of cancer cells, referred to as cancer stem cells (CSCs), plays a critical role in tumor initiation, metastatic colonization, and resistance to therapy. Although the signals generated by the metastatic niche that regulate CSCs are not yet fully understood, accumulating evidence suggests a key role of the CXCL12/CXCR4 axis. In this review we focus on physiological functions of the CXCL12/CXCR4 signaling pathway and its role in cancer and CSCs, and we discuss the potential for targeting this pathway in cancer management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-κB
Maroni, P., Bendinelli, P., Matteucci, E., & Desiderio, M. A. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl129 · Cited by 95
RetractedProspective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS
Gilman, A. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003151 · Cited by 6,381
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,701
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,489
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,826
Ma, Q., Jones, D., Borghesani, P. R., Segal, R. A., Nagasawa, T., Kishimoto, T., Bronson, R. T., & Springer, T. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9448 · Cited by 1,682
A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., & Springer, T. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1101 · Cited by 1,482
CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Teicher, B. A., & Fricker, S. P. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2329 · Cited by 1,449
Migrating cancer stem cells — an integrated concept of malignant tumour progression
Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., & Kirchner, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1694 · Cited by 1,352
Cancer Stem Cells: Models and Concepts
Dalerba, P., Cho, R. W., & Clarke, M. F. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.062105.204854 · Cited by 1,274
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2006) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,170
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Shackleton, M., Quintana, E., Fearon, E. R., & Morrison, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.08.017 · Cited by 1,162
Aiuti, A., Webb, I. J., Bleul, C., Springer, T., & Gutierrez-Ramos, J. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.1.111 · Cited by 1,158
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors
Moeller, B. J., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00115-1 · Cited by 996
The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells
Liu, R., Wang, X., Chen, G. Y., Dalerba, P., Gurney, A., Hoey, T., Sherlock, G., Lewicki, J., Shedden, K., & Clarke, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063994 · Cited by 985
Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells
Mishra, P. J., Mishra, P. J., Humeniuk, R., Medina, D. J., Alexe, G., Mesirov, J. P., Ganesan, S., Glod, J. W., & Banerjee, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0943 · Cited by 912
Foxo3a is essential for maintenance of the hematopoietic stem cell pool
Miyamoto, K., Kazuhito, N., & Atsushi, H. (2009) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 892
Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression
Liang, J., & Slingerland, J. M. (2003) · Cell Cycle · doi:10.4161/cc.2.4.433 · Cited by 885
Cancer stem cells and epithelial–mesenchymal transition: Concepts and molecular links
Scheel, C., & Weinberg, R. A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.04.001 · Cited by 881
Exploring the role of cancer stem cells in radioresistance
Baumann, M., Krause, M., & Hill, R. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2419 · Cited by 815
Heddleston, J. M., Li, Z., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9701 · Cited by 813
Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type
Orimo, A., & Weinberg, R. A. (2006) · Cell Cycle · doi:10.4161/cc.5.15.3112 · Cited by 799
Kioi, M., Vogel, H., Schultz, G., Hoffman, R. M., Harsh, G. R., & Brown, J. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40283 · Cited by 773
Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska‐Wieczorek, A., Ratajczak, J., & Ratajczak, M. Z. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0342 · Cited by 759
The significance of cancer cell expression of the chemokine receptor CXCR4
Balkwill, F. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.003 · Cited by 758
Aktas, B., Tewes, M., Fehm, T., Hauch, S., Kimmig, R., & Kasimir-Bauer, S. (2009) · Breast Cancer Research · doi:10.1186/bcr2333 · Cited by 736
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
Sun, X., Cheng, G., Hao, M., Zheng, J., Zhou, X., Zhang, J., Taichman, R. S., Pienta, K. J., & Wang, J. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9256-x · Cited by 727
CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer
Smith, M. C. P., Luker, K. E., Garbow, J. R., Prior, J. L., Jackson, E., Piwnica-Worms, D., & Luker, G. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1844 · Cited by 715
CXCR4–SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion
Kucia, M., Jankowski, K., Reca, R., Wysoczynski, M., Bandura, L., Allendorf, D. J., Zhang, J., Ratajczak, J., & Ratajczak, M. Z. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032355.66152.b8 · Cited by 698
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
Soeda, A., Park, M., Lee, D., Mintz, A., Androutsellis-Theotokis, A., McKay, R. D., Engh, J., Iwama, T., Kunisada, T., Kassam, A. B., et al. (2009) · Oncogene · doi:10.1038/onc.2009.252 · Cited by 656
Armstrong, A. J., Marengo, M. S., Oltean, S., Kemeny, G., Bitting, R. L., Turnbull, J. D., Herold, C. I., Marcom, P. K., George, D. J., & Garcia-Blanco, M. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0490 · Cited by 646
The role of CXC chemokines and their receptors in cancer
Vandercappellen, J., Van Damme, J., & Struyf, S. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.050 · Cited by 643
Helbig, G., Christopherson, K. W., Bhat-Nakshatri, P., Kumar, S., Kishimoto, H., Miller, K. D., Broxmeyer, H. E., & Nakshatri, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300609200 · Cited by 639
Hypoxic Radiosensitization: Adored and Ignored
Overgaard, J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7878 · Cited by 619
Busillo, J. M., & Benovic, J. L. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.11.002 · Cited by 617
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
Rubin, J. B., Kung, A. L., Klein, R. S., Chan, J. A., Sun, Y., Schmidt, K., Kieran, M. W., Luster, A. D., & Segal, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235846100 · Cited by 615
The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis
Petit, I., Jin, D., & Rafii, S. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.05.007 · Cited by 603
Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation
Viola, A., & Luster, A. D. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.121806.154841 · Cited by 583
Dubrovska, A., Kim, S., Salamone, R. J., Walker, J. R., Maira, S.-M., García-Echeverría, C., Schultz, P. G., & Reddy, V. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810956106 · Cited by 564
Self-citationUnderstanding cancer stem cell heterogeneity and plasticity
Tang, D. G. (2012) · Cell Research · doi:10.1038/cr.2012.13 · Cited by 563
A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
Pang, R., Law, W. L., Chu, A. C. Y., Poon, J. T., Lam, C. S. C., Chow, A. K. M., Ng, L., Cheung, L. W. H., Lan, X. R., Lan, H. Y., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.001 · Cited by 540
Burger, J. A., Burger, M., & Kipps, T. J. (1999) · Blood · doi:10.1182/blood.v94.11.3658 · Cited by 507
The chemokine SDF‐lα triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway
Vila‐Coro, A. J., Rodríguez‐Frade, J. M., De Ana, A. M., Moreno‐Ortíz, M. C., Martínez‐A., C., & Mellado, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.13.1699 · Cited by 506
G-protein signaling: back to the future
McCudden, C. R., Hains, M. D., Kimple, R. J., Siderovski, D. P., & Willard, F. S. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4462-3 · Cited by 505
Hendrix, C. W., Flexner, C., MacFarland, R. T., Giandomenico, C., Fuchs, E. J., Redpath, E., Bridger, G., & Henson, G. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1667-1673.2000 · Cited by 504
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)–dependent migration and homing in multiple myeloma
Alsayed, Y., Ngo, H., Runnels, J., Leleu, X., Singha, U. K., Pitsillides, C. M., Spencer, J. A., Kimlinger, T., Ghobrial, J. M., Jia, X., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035857 · Cited by 478
Liu, H., Patel, M. R., Prescher, J. A., Patsialou, A., Qian, D., Lin, J., Wen, S., Chang, Y.-F., Bachmann, M. H., Shimono, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006732107 · Cited by 465
De Clercq, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1134 · Cited by 460
Fuks, Z., Leibel, S. A., Wallner, K. E., Begg, C. B., Fair, W. R., Anderson, L. L., Hilaris, B. S., & Whitmore, W. F. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90668-t · Cited by 448
Chemokine receptor homo- or heterodimerization activates distinct signaling pathways
Mellado, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2497 · Cited by 432
Azab, A. K., Runnels, J. M., Pitsillides, C., Moreau, A.-S., Azab, F., Leleu, X., Jia, X., Wright, R., Ospina, B., Carlson, A. L., et al. (2009) · Blood · doi:10.1182/blood-2008-10-186668 · Cited by 428
The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis
Ratajczak, M. Z., Zuba-Surma, E., Kucia, M., Reca, R., Wojakowski, W., & Ratajczak, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404357 · Cited by 424
Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis
Jung, Y., Kim, J. K., Shiozawa, Y., Wang, J., Mishra, A., Joseph, J., Berry, J. E., McGee, S., Lee, E., Sun, H., et al. (2013) · Nature Communications · doi:10.1038/ncomms2766 · Cited by 423
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
Darash-Yahana, M., Pikarsky, E., Abramovitch, R., Zeira, E., Pal, B., Karplus, R., Beider, K., Avniel, S., Kasem, S., Galun, E., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0935fje · Cited by 421
The evolving concept of cancer and metastasis stem cells
Baccelli, I., & Trumpp, A. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201202014 · Cited by 412
Zagzag, D., Lukyanov, Y., Lan, L., Ali, M. A., Esencay, M., Mendez, O., Yee, H., Voura, E. B., & Newcomb, E. W. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700482 · Cited by 396
Mellado, M., Rodríguez-Frade, J. M., Mañes, S., & Martínez-A, C. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.397 · Cited by 390
Sun, Y., Cheng, Z., Ma, L., & Pei, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207294200 · Cited by 382
Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
Luttrell, L. M., Gesty-Palmer, D., & Sibley, D. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002436 · Cited by 369
Zernecke, A., Schober, A., Bot, I., von Hundelshausen, P., Liehn, E. A., Möpps, B., Mericskay, M., Gierschik, P., Biessen, E. A., & Weber, C. (2005) · Circulation Research · doi:10.1161/01.res.0000162100.52009.38 · Cited by 364
CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival
Zhou, Y., Larsen, P. H., Hao, C., & Yong, V. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206222200 · Cited by 363
CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration
Décaillot, F. M., Kazmi, M. A., Lin, Y., Ray-Saha, S., Sakmar, T. P., & Sachdev, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277038 · Cited by 333
Zhang, R., & Xie, X. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.173 · Cited by 317
Furusato, B., Mohamed, A., Uhlén, M., & Rhim, J. S. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02548.x · Cited by 290
Functions of CXCL12 and CXCR4 in breast cancer
Luker, K. E., & Luker, G. D. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.06.021 · Cited by 288
Lazarini, F., Tham, T. N., Casanova, P., Arenzana‐Seisdedos, F., & Dubois‐Dalcq, M. (2003) · Glia · doi:10.1002/glia.10139 · Cited by 280
Hartmann, T. N., Burger, J. A., Glodek, A., Fujii, N., & Burger, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208621 · Cited by 280
Ratajczak, M. Z., Majka, M., Kucia, M., Drukala, J., Pietrzkowski, Z., Peiper, S., & Janowska-Wieczorek, A. (2003) · Stem Cells · doi:10.1634/stemcells.21-3-363 · Cited by 279
Kozin, S. V., Kamoun, W. S., Huang, Y., Dawson, M. R., Jain, R. K., & Duda, D. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4446 · Cited by 277
Shuman Moss, L. A., Jensen-Taubman, S., & Stetler-Stevenson, W. G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.08.044 · Cited by 271
Asiedu, M. K., Ingle, J. N., Behrens, M. D., Radisky, D. C., & Knutson, K. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4554 · Cited by 270
Cytokines and hematopoietic stem cell mobilization
Nervi, B., Link, D. C., & DiPersio, J. F. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21043 · Cited by 257
Pharmacological modulation of chemokine receptor function
Scholten, D., Canals, M., Maussang, D., Roumen, L., Smit, M., Wijtmans, M., de Graaf, C., Vischer, H., & Leurs, R. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01551.x · Cited by 248
Righi, E., Kashiwagi, S., Yuan, J., Santosuosso, M., Leblanc, P., Ingraham, R., Forbes, B., Edelblute, B., Collette, B., Xing, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3143 · Cited by 245
Chinni, S. R., Sivalogan, S., Dong, Z., Filho, J. C. T., Deng, X., Bonfil, R. D., & Cher, M. L. (2006) · The Prostate · doi:10.1002/pros.20318 · Cited by 245
Cancer Stem Cells, Hypoxia and Metastasis
Hill, R. P., Marie-Egyptienne, D. T., & Hedley, D. W. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.12.002 · Cited by 238
Identification and expression of novel isoforms of human stromal cell-derived factor 1
Yu, L., Cecil, J., Peng, S.-B., Schrementi, J., Kovacevic, S., Paul, D., Su, E. W., & Wang, J. (2006) · Gene · doi:10.1016/j.gene.2006.02.001 · Cited by 232
Distant metastases after irradiation alone in carcinoma of the uterine cervix
Fagundes, H., Perez, C. A., Grigsby, P. W., & Lockett, M. A. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90671-4 · Cited by 224
Kijowski, J., Baj‐Krzyworzeka, M., Majka, M., Reca, R., Marquez, L. A., Christofidou‐Solomidou, M., Janowska‐Wieczorek, A., & Ratajczak, M. Z. (2001) · STEM CELLS · doi:10.1634/stemcells.19-5-453 · Cited by 224
Extracellular matrix alters PDGF regulation of fibroblast integrins.
Xu, J., & Clark, R. A. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.1.239 · Cited by 224
Kajiyama, H., Shibata, K., Terauchi, M., Ino, K., Nawa, A., & Kikkawa, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23083 · Cited by 220
Cheng, Z.-J., Zhao, J., Sun, Y., Hu, W., Wu, Y.-L., Cen, B., Wu, G.-X., & Pei, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2479 · Cited by 219
Kukreja, P., Abdel-Mageed, A. B., Mondal, D., Liu, K., & Agrawal, K. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1293 · Cited by 209
CXCR7 impact on CXCL12 biology and disease
Sánchez-Martín, L., Sánchez-Mateos, P., & Cabañas, C. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.10.004 · Cited by 206
Jung, M.-J., Rho, J.-K., Kim, Y.-M., Jung, J. E., Jin, Y. B., Ko, Y.-G., Lee, J.-S., Lee, S.-J., Lee, J. C., & Park, M.-J. (2013) · Oncogene · doi:10.1038/onc.2012.37 · Cited by 201
Heterotrimeric G-protein βγ-dimers in growth and differentiation
Schwindinger, W. F., & Robishaw, J. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204181 · Cited by 199
Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12
Singh, A. K., Arya, R. K., Trivedi, A. K., Sanyal, S., Baral, R., Dormond, O., Briscoe, D. M., & Datta, D. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.08.007 · Cited by 194
Low Doses of Ionizing Radiation Promote Tumor Growth and Metastasis by Enhancing Angiogenesis
Sofia Vala, I., Martins, L. R., Imaizumi, N., Nunes, R. J., Rino, J., Kuonen, F., Carvalho, L. M., Rüegg, C., Grillo, I. M., Barata, J. T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011222 · Cited by 194
CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
Domanska, U. M., Timmer-Bosscha, H., Nagengast, W. B., Oude Munnink, T. H., Kruizinga, R. C., Ananias, H. J. K., Kliphuis, N. M., Huls, G., De Vries, E. G. E., de Jong, I. J., et al. (2012) · Neoplasia · doi:10.1593/neo.12324 · Cited by 191
Discovery of the cancer stem cell related determinants of radioresistance
Peitzsch, C., Kurth, I., Kunz-Schughart, L., Baumann, M., & Dubrovska, A. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.003 · Cited by 189
Self-citationMöhle, R., Failenschmid, C., Bautz, F., & Kanz, L. (1999) · Leukemia · doi:10.1038/sj.leu.2401602 · Cited by 184
Zeng, Z., Samudio, I. J., Munsell, M., An, J., Huang, Z., Estey, E., Andreeff, M., & Konopleva, M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0228 · Cited by 184
Stromal Derived Factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis
Pan, J., Mestas, J., Burdick, M. D., Phillips, R. J., Thomas, G. V., Reckamp, K., Belperio, J. A., & Strieter, R. M. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-56 · Cited by 184
Gerits, N., Kostenko, S., Shiryaev, A., Johannessen, M., & Moens, U. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.02.022 · Cited by 182
Fareh, M., Turchi, L., Virolle, V, Debruyne, D., Almairac, F., de-la-Forest Divonne, S., Paquis, P., Preynat-Seauve, O., Krause, K.-H., Chneiweiss, H., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.89 · Cited by 180
Integrins in prostate cancer progression
Goel, H. L., Li, J., Kogan, S., & Languino, L. R. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0019 · Cited by 180
CXCR4 Chemokine Receptor Mediates Prostate Tumor Cell Adhesion through α5 and β3 Integrins
Engl, T., Relja, B., Marian, D., Blumenberg, C., Müller, I., Beecken, W.-D., Jones, J., Ringel, E. M., Bereiter-Hahn, J., Jonas, D., et al. (2006) · Neoplasia · doi:10.1593/neo.05694 · Cited by 179
Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells
Jordan, N. J., Kolios, G., Abbot, S. E., Sinai, M. A., Thompson, D. A., Petraki, K., & Westwick, J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6685 · Cited by 174
High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
Maréchal, R., Demetter, P., Nagy, N., Berton, A., Decaestecker, C., Polus, M., Closset, J., Devière, J., Salmon, I., & Van Laethem, J.-L. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605020 · Cited by 173
Rozengurt, E. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199812)177:4<507::aid-jcp2>3.0.co;2-k · Cited by 171
Sun, Y., Fang, M., Wang, J., Cooper, C. R., Pienta, K. J., & Taichman, R. S. (2007) · The Prostate · doi:10.1002/pros.20500 · Cited by 171
Kim, M., Koh, Y. J., Kim, K. E., Koh, B. I., Nam, D.-H., Alitalo, K., Kim, I., & Koh, G. Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2591 · Cited by 168
CD133+CXCR4+ colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
Zhang, S.-S., Han, Z.-P., Jing, Y.-Y., Tao, S.-F., Li, T.-J., Wang, H., Wang, Y., Li, R., Yang, Y., Zhao, X., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-85 · Cited by 164
β‐arrestins and heterotrimeric G‐proteins: collaborators and competitors in signal transduction
DeFea, K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707508 · Cited by 162
Matsusue, R., Kubo, H., Hisamori, S., Okoshi, K., Takagi, H., Hida, K., Nakano, K., Itami, A., Kawada, K., Nagayama, S., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0599-x · Cited by 161
Porcile, C., Bajetto, A., Barbieri, F., Barbero, S., Bonavia, R., Biglieri, M., Pirani, P., Florio, T., & Schettini, G. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.04.024 · Cited by 159
Cabıoğlu, N., Summy, J. M., Miller, C. P., Parikh, N. U., Şahin, A. A., Tuzlalı, S., Pumiglia, K. M., Gallick, G. E., & Price, J. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1303 · Cited by 157
Shangguan, L., Ti, X., Krause, U., Hai, B., Zhao, Y., Yang, Z., & Liu, F. (2012) · Stem Cells · doi:10.1002/stem.1251 · Cited by 156
Nguyen, D. H. A., Oketch‐Rabah, H. A., Illa-Bochaca, I., Geyer, F. C., Reis-Filho, J. S., Mao, J., Ravani, S. A., Zavadil, J., Borowsky, A. D., Jerry, D. J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.011 · Cited by 156
Functional diversity of SDF-1 splicing variants
Janowski, M. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.3.8260 · Cited by 155
Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression
New, D. C., & Wong, Y. H. (2007) · Journal of Molecular Signaling · doi:10.1186/1750-2187-2-2 · Cited by 155
Yaromina, A., Krause, M., Thames, H. D., Rosner, A., Krause, M., Hessel, F., Grenman, R. A., Zips, D., & Baumann, M. A. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.020 · Cited by 153
Chemokines in vascular remodeling
Zernecke, A., & Schober, A. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-02-0085 · Cited by 152
Dong, F., Harvey, J. E., Finan, A., Weber, K., Agarwal, U., & Penn, M. S. (2012) · Circulation · doi:10.1161/circulationaha.111.082453 · Cited by 152
Radiation enhancement of metastasis: a review
von Essen, C. F. (1991) · Clinical & Experimental Metastasis · doi:10.1007/bf01756381 · Cited by 146
Chinni, S., Yamamoto, H., Dong, Z.-Y., Sabbota, A. L., Bonfil, R., & Cher, M. L. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0117 · Cited by 146
Hypoxia and Hypoxia Inducible Factors in Cancer Stem Cell Maintenance
Li, Z., & Rich, J. N. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_75 · Cited by 142
New insights on the role of CXCR4 in cancer metastasis
Zlotnik, A. (2008) · The Journal of Pathology · doi:10.1002/path.2350 · Cited by 140
CXCR4 Inhibition Synergizes with Cytotoxic Chemotherapy in Gliomas
Redjal, N., Chan, J. A.-W., Segal, R. A., & Kung, A. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1372 · Cited by 138
The CXCL12–CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies
Epstein, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1473 · Cited by 134
Shen, W., Bendall, L. J., Gottlieb, D. J., & Bradstock, K. F. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00741-x · Cited by 134
CXCR4 Expression in Prostate Cancer Progenitor Cells
Dubrovska, A., Elliott, J., Salamone, R. J., Телегеев, Г. Д., Stakhovskyi, A. E., Schepotin, I. B., Yan, F., Wang, Y., Bouchez, L. C., Kularatne, S. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031226 · Cited by 134
Self-citationTNF-α mediates SDF-1α–induced NF-κB activation and cytotoxic effects in primary astrocytes
Han, Y., He, T., Huang, D., Pardo, C. A., & Ransohoff, R. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12629 · Cited by 134
Chen, G. T. Y., Chiang, C., Wang, C., Tsai, C.-S., Jung, S., Lee, C.-C., McBride, W. H., & Hong, J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1471 · Cited by 133
In vitro generation of human cells with cancer stem cell properties
Scaffidi, P., & Misteli, T. (2011) · Nature Cell Biology · doi:10.1038/ncb2308 · Cited by 126
Heinrich, E. L., Lee, W., Lu, J., Lowy, A. M., & Kim, J. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-68 · Cited by 125
Gassenmaier, M., Chen, D., Büchner, A., Henkel, L., Schiemann, M., Mack, B., Schendel, D. J., Zimmermann, W., & Pohla, H. (2013) · Stem Cells · doi:10.1002/stem.1407 · Cited by 124
CXCL12 increases human neural progenitor cell proliferation through Akt‐1/FOXO3a signaling pathway
Wu, Y., Peng, H., Cui, M., Whitney, N. P., Huang, Y., & Zheng, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06043.x · Cited by 121
Dubrovska, A., Elliott, J., Salamone, R. J., Kim, S., Aimone, L. J., Walker, J. R., Watson, J., Maira, S.-M., García-Echeverría, C., Cho, C. Y., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1601 · Cited by 121
Self-citationDubrovska, A., Hartung, A., Bouchez, L. C., Walker, J. R., Reddy, V. A., Cho, C. Y., & Schultz, P. G. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.105 · Cited by 119
Self-citationG-protein-coupled receptor expression, function, and signaling in macrophages
Lattin, J. E., Zidar, D. A., Schroder, K., Kellie, S., Hume, D. A., & Sweet, M. J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0107051 · Cited by 117
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
Popple, A. L., Durrant, L. G., Spendlove, I., Rolland, P. D., Scott, I., Deen, S., & Ramage, J. M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.49 · Cited by 115
Yu, J., Li, M., Qu, Z., Yan, D., Li, D., & Ruan, Q. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181d7a384 · Cited by 113
Peng, S.-B., Peek, V. L., Zhai, Y., Paul, D. C., Lou, Q., Xia, X., Eessalu, T. E., Kohn, W. D., & Tang, S. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0193 · Cited by 107
PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1α
Eke, I., Koch, U., Hehlgans, S., Sandfort, V., Stanchi, F., Zips, D., Baumann, M. A., Shevchenko, A., Pilarsky, C. P., Haase, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41078 · Cited by 101
Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma
Nakashiro, K. (2009) · Oncology Reports · doi:10.3892/or_00000275 · Cited by 99
Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension
Gambaryan, N., Perros, F., Montani, D., Cohen‐Kaminsky, S., Mazmanian, M. G., Renaud, J. F., Simonneau, G., Lombet, A., & Humbert, M. J. C. (2010) · European Respiratory Journal · doi:10.1183/09031936.00045710 · Cited by 98
Ahmed, K. M., Zhang, H., & Park, C. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3537 · Cited by 97
Eck, S. M., Côté, A. L., Winkelman, W. D., & Brinckerhoff, C. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0015 · Cited by 93
The chemokine receptor CXCR7 functions to regulate cardiac valve remodeling
Yu, S., Crawford, D., Tsuchihashi, T., Behrens, T. W., & Srivastava, D. (2011) · Developmental Dynamics · doi:10.1002/dvdy.22549 · Cited by 92
Zhu, S., Evans, S., Yan, B., Povsic, T. J., Tapson, V. F., Goldschmidt‐Clermont, P. J., & Dong, C. (2008) · Circulation · doi:10.1161/circulationaha.108.787200 · Cited by 90
Zhu, B., Xu, D., Deng, X., Chen, Q., Huang, Y., Peng, H., Li, Y., Jia, B., Thoreson, W. B., Ding, W., et al. (2012) · Stem Cells · doi:10.1002/stem.1239 · Cited by 89
Kuonen, F., Secondini, C., & Rüegg, C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1758 · Cited by 89
Foxo Factors: A Matter of Life and Death
Huang, H., & Tindall, D. J. (2006) · Future Oncology · doi:10.2217/14796694.2.1.83 · Cited by 88
Sun, X., Lei, W., Chen, Q., & Terek, R. M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-17 · Cited by 87
Development of novel CXCR4-based therapeutics
Peled, A., Wald, O., & Burger, J. A. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.656197 · Cited by 85
Ho, T. K., Shiwen, X., Abraham, D., Tsui, J. C. S., & Baker, D. (2012) · Cardiology Research and Practice · doi:10.1155/2012/143209 · Cited by 75
Princen, K., Hatse, S., Vermeire, K., Clercq, E. D., & Schols, D. (2002) · Cytometry Part A · doi:10.1002/cyto.a.10008 · Cited by 74
Kim, H.-C., Choi, K., Choi, H., Kang, H., Kim, M., Lee, Y., Lee, O., Lee, J., Kim, Y. J., Jun, W., et al. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0388-5 · Cited by 73
Smith, H. K., Whittall, C. M., Weksler, B. B., & Middleton, J. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0025 · Cited by 71
Inhibition of CXCR4–CXCL12 chemotaxis in melanoma by AMD11070
O’Boyle, G., Swidenbank, I., Marshall, H. L., Barker, C. E., Armstrong, J., White, S., Fricker, S. P., Plummer, R., Wright, M. C., & Lovat, P. E. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.124 · Cited by 70
Halting metastasis through CXCR4 inhibition
Ramsey, D. M., & McAlpine, S. R. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.10.138 · Cited by 69
Epigenetic Changes of CXCR4 and Its Ligand CXCL12 as Prognostic Factors for Sporadic Breast Cancer
Ramos, E. A. D. S., Grochoski, M., Braun-Prado, K., Seniski, G. G., Cavalli, I. J., Ribeiro, E. M. S. F., Camargo, A. A., Costa, F. F., & Klassen, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029461 · Cited by 67
Clinicopathologic Significance of HIF‐1 α , CXCR4, and VEGF Expression in Colon Cancer
Wu, Y., Jin, M., Xu, H., Shimin, Z., He, S., Wang, L., & Zhang, Y. (2010) · Journal of Immunology Research · doi:10.1155/2010/537531 · Cited by 67
Bennani-Baı̈ti, I. M., Cooper, A. R., Lawlor, E. R., Kauer, M. O., Ban, J., Aryee, D. N. T., & Kovar, H. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0558 · Cited by 67
Eck, S. M., Blackburn, J. S., Schmucker, A. C., Burrage, P. S., & Brinckerhoff, C. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.011 · Cited by 65
Ou, D., Chen, C., Lin, S., Hsu, C., & Lin, L. (2006) · The Journal of Pathology · doi:10.1002/path.2053 · Cited by 63
The Fibroblast — A Ubiquitous Ally for the Surgeon
Dunphy, J. E. (1963) · New England Journal of Medicine · doi:10.1056/nejm196306202682501 · Cited by 62
HGF upregulates CXCR4 expression in gliomas via NF-κB: implications for glioma cell migration
Esencay, M., Newcomb, E. W., & Zagzag, D. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0111-2 · Cited by 61
CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges
de Nigris, F., Schiano, C., Infante, T., & Claudio Napoli, A. (2012) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489212801820039 · Cited by 61
Agle, K. A., Vongsa, R. A., & Dwinell, M. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.061416 · Cited by 60
Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases
Uchida, D., Onoue, T., Kuribayashi, N., Tomizuka, Y., Tamatani, T., Nagai, H., & Miyamoto, Y. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.09.028 · Cited by 60
Inhibition of stromal CXCR4 impairs development of lung metastases
D’Alterio, C., Barbieri, A., Portella, L., Palma, G., Polimeno, M., Riccio, A., Ieranò, C., Franco, R., Scognamiglio, G., Bryce, J., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1223-7 · Cited by 60
Impaired chemokine‐induced migration during T‐cell development in the absence of Jak 3
Soldevila, G., Licona‐Limón, I., Salgado-Aguayo, A. R., Ramírez, M., Chávez-Ríos, J. R., & García-Zepeda, E. A. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01863.x · Cited by 55
CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells
Jones, J., Marian, D., Weich, E., et al. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.07.001 · Cited by 54
Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression
Jin, Z. X., Zhao, C., Han, X., & Han, Y. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-480 · Cited by 53
Regulation of CXCL12 expression by canonical Wnt signaling in bone marrow stromal cells
Tamura, M., Sato, M. M., & Nashimoto, M. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.01.021 · Cited by 51
Expression of chemokine receptors on circulating tumor cells in patients with solid tumors
Fusi, A., Liu, Z., Kümmerlen, V., Nonnemacher, A., Jeske, J., & Keilholz, U. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-52 · Cited by 50
Yu, L., & Hales, C. A. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-21 · Cited by 50
Ou, J., Luan, W., Deng, J., Sa, R., & Liang, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038737 · Cited by 49
Zhang, L., Ye, S., Ma, G., Tang, X.-F., Chen, S.-P., He, J., Liu, W.-L., Xie, D., Zeng, Y.-X., & Li, J. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-60 · Cited by 49
Uchida, D., Onoue, T., Begum, N.-M., Kuribayashi, N., Tomizuka, Y., Tamatani, T., Nagai, H., & Miyamoto, Y. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-62 · Cited by 46
Hematopoietic stem cell derived carcinoma-associated fibroblasts: a novel origin.
McDonald, L. T., & LaRue, A. C. (2012) · PubMed · Cited by 45
Karshovska, E., Zagorac, D., Zernecke, A., Weber, C., & Schober, A. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03086.x · Cited by 43
Foxo3a is essential for maintenance of the hematopoietic stem cell pool.
Miyamoto, K., Araki, K. Y., Naka, K., Arai, F., Takubo, K., Yamazaki, S., Matsuoka, S., Miyamoto, T., Ito, K., Ohmura, M., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.02.001 · Cited by 41
[FoxO3a is essential for the maintenance of hematopoietic stem cell pool].
Miyamoto, K. (2008) · PubMed · Cited by 41
Wang, M., Chen, G., Song, H., Hong, X., Yang, Z., & Sui, G. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.235 · Cited by 38
CXCR4-Positive Subset of Glioma Is Enriched for Cancer Stem Cells
Zheng, X., Xie, Q., Li, S., & Zhang, W. (2011) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504012x13340632812631 · Cited by 37
The role of the CXCR4 cell surface chemokine receptor in glioma biology
Ehtesham, M., Min, E., Issar, N. M., Kasl, R. A., Khan, I. S., & Thompson, R. C. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1108-4 · Cited by 35
Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors
Hindriksen, S., & Bijlsma, M. F. (2012) · Cancers · doi:10.3390/cancers4040989 · Cited by 35
Matteucci, E., Ridolfi, E., Maroni, P., Bendinelli, P., & Desiderio, M. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0054 · Cited by 32
Wang, J., Cai, J., Han, F., Yang, C., Tong, Q., Cao, T., Wu, L., & Wang, Z. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31821d2543 · Cited by 32
Hiller, D. J., Meschonat, C., Kim, R. H., Li, B. D. �., & Chu, Q. D. (2011) · Surgery · doi:10.1016/j.surg.2011.07.005 · Cited by 30
Bettink, S., Werner, C. M., Chen, C., Müller, P., Schirmer, S. H., Walenta, K. L. H., Böhm, M., Laufs, U., & Friedrich, E. B. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.086 · Cited by 28
Dynamic regulation of ROCK in tumor cells controls CXCR4-driven adhesion events
Struckhoff, A. P., Vitko, J. R., Rana, M. K., Davis, C. T., Foderingham, K. E., Liu, C.-H., Rhodes, L. V., Elliot, S., Zhu, Y., Burow, M., et al. (2010) · Journal of Cell Science · doi:10.1242/jcs.052167 · Cited by 28
A novel role of CXCR4 and SDF‐1 during migration of cloacal muscle precursors
Rehimi, R., Khalida, N., Yusuf, F., Moroşan‐Puopolo, G., & Brand‐Saberi, B. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22288 · Cited by 24
Day, C. E., Guillén, C., Willars, G. B., & Wardlaw, A. J. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03257.x · Cited by 12
Cited by
Role of the Tumor Microenvironment in Breast Cancer
Soysal, S. D., Tzankov, A., & Muenst, S. E. (2015) · Pathobiology · doi:10.1159/000430499 · Cited by 510
A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
Cojoc, M., Mäbert, K., Muders, M. H., & Dubrovska, A. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.06.004 · Cited by 393
Self-citationHerrmann, K., Schottelius, M., Lapa, C., Osl, T., Poschenrieder, A., Hänscheid, H., Lückerath, K., Schreder, M., Bluemel, C., Knott, M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.167361 · Cited by 276
CXCR4 signaling in health and disease
Pozzobon, T., Goldoni, G., Viola, A., & Molon, B. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.06.006 · Cited by 256
López de Andrés, J., Griñán-Lisón, C., Jiménez, G., & Marchal, J. A. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00966-3 · Cited by 207
Metadata
- Authors
- Dubrovska, A., Cojoc, M., Peitzsch, Trautmann, F., Polishchuk, & Telegeev
- Venue
- OncoTargets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2013-09
- Volume
- 6
- Pages
- 1347
- ISSN
- 1178-6930 (ISSN-L)
- OpenAlex
- W2053911435
- Cited by
- 254
- References
- 198
- FWCI
- 15.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.